F8 and autoimmune hemolytic anemia: The majority of FVIII inhibitors observed in AHA, which are polyclonal autoantibodies, and in congenital hemophilia A, which are polyclonal alloantibodies, bind to the A2 (454–509), A3 (1804–1819), or C2 domains (2181–2243) [14–17].